
Elanco outlook revised to positive by S&P Global on reduced leverage
Investing.com -- S&P Global Ratings has revised its outlook for Elanco Animal Health (NYSE:ELAN) Inc. from stable to positive, citing reduced leverage and strong revenue growth potential. The company ended 2024 with net leverage of less than 4.5x, a level S&P Global Ratings views as consistent with a higher rating. This was achieved through the use of proceeds from a divestiture to pay d ...